Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene.
about
Human immunodeficiency virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides.Optimization of the oligonucleotide ligation assay for the detection of nevirapine resistance mutations in Zimbabwean Human Immunodeficiency Virus type-1 subtype CTransmitted HIV resistance to first-line antiretroviral therapy in Lima, Peru.Application of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virus.Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-North American variants.Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.
P2860
Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Development and evaluation of ...... iciency virus type 2 pol gene.
@en
type
label
Development and evaluation of ...... iciency virus type 2 pol gene.
@en
prefLabel
Development and evaluation of ...... iciency virus type 2 pol gene.
@en
P2093
P2860
P50
P356
P1476
Development and evaluation of ...... ficiency virus type 2 pol gene
@en
P2093
Eleonor Brandin
Guido Vanham
Hilton Whittle
Jan Albert
Martin Schutten
Sarah Rowland-Jones
Steve Kaye
Wouter Janssens
P2860
P304
P356
10.1128/JCM.02220-06
P407
P577
2007-02-28T00:00:00Z